Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECICE: Duloxetine and CBT for Chronic Musculoskeletal Pain
NCT04395001Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of duloxetine in chronic musculoskeletal pain (3 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Brief Pain Inventory Total Pain Severity at Week 25. Started Feb 2021; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic musculoskeletal pain
Beyond the preview
Go deeper on NCT04395001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04395001.